Ex Vivo Perfusion of the Heart with an Aim to Increase Viable Hearts for Transplantation (EP Video)
The race is on to develop an affordable, hybridized ex vivo heart perfusion system in which load-independent biventricular contractility and contractile reserve can be measured (26:40 minutes).
Open Forum on Platelet Therapy & Clinical & Feasible Regenerative Medicine Treatment Options in the OR (EP Video)
The regenerative medicine market today includes first of all platelet-rich plasma (PRP) products, brought to market by a large variety of medical companies (52:34 minutes).
Autologous Blood Management Strategies in Cardiac Surgery (EP Video)
In order to minimize the risks and adverse effects after transfusing homologous blood products, new strategies of autologous blood management (ABM) have been introduced in cardiac surgery (45:11 minutes).
The Establishment & Use of TEG in a Pediatric Institution (EP Video)
In this presentation, Kathy will discuss the clinical use of TEG in the pediatric setting, describe how we recently implemented the test at our institution, and discuss several pediatric cases in which TEG results had an impact on patient treatment (36:51 minutes).
Terumo: Optimizing Blood Management (EP Video)
Stephen Roller presents on Terumo's product offerings designed to optimize patient blood management (15:13 minutes).
Adipose Stem Cells, The Emerging Field (EP Video)
J.D. Fritz discusses the emerging field of Adipose Stem Cells (26:00 minutes).
TEG use in CV & Trauma Cases (EP Video)
This program will provide a basic overview of the TEG Hemostasis Analyzer and then focus on case studies in CV surgery, CV patient stratification, Trauma cases and a case study on Pradaxa (42:50 minutes).
Electronic Perfusion Data Management: A Gigabyte of Info (EP Video)
With perfusion being such a small specialty, how do our data management solutions fit into the big picture of EHR adoption? This presentation attempts to answer this question and further discusses how to assess the current options on the market in relation to federal, institutional, and departmental goals (24:49 minutes).
Emergency Preparedness: Are You Ready? (EP Video)
Failure Mode Effects Analysis, FMEA, is a technique which will help us to be proactive for risk analysis. Perfusion safety will be defined and six steps to perfusion safety will be reviewed. Practical benefits to having a perfusion FMEA will be discussed to see if your perfusion program is ready for an emergency (45:59 minutes).
Cannulation Disaster Management (EP Video)
By understanding the nuances of minimally invasive cardiac surgical perfusion techniques one can hopefully avoid and if necessary successfully navigate most unexpected complications (47:58 minutes).
Hemodynamics in Heart Failure, and the Effects of New Interventions (EP Video)
Heart failure can be the result of a wide range of disorders, including coronary ischemic heart disease, myocardial diseases, and valvular heart disease. Specific treatments address the underlying pathophysiology of the disorder. By reviewing hemodynamic and pressure-volume relationships in disease, we can think about tailoring our therapy to the needs of the patient (46:14 minutes).
IABP Sizing Impact On Augmentation (EP Video)
This presentation aims to address the topic of IAB sizing and its correlation to therapy as well as strategies to optimize size on an individual basis (32:38 minutes).